Production (Stage)
PROCEPT BioRobotics Corporation
PRCT
$57.38
-$0.34-0.59%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 55.28% | 56.57% | 66.29% | 61.17% | 82.51% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 55.28% | 56.57% | 66.29% | 61.17% | 82.51% |
| Cost of Revenue | 28.18% | 10.02% | 32.23% | 49.04% | 63.73% |
| Gross Profit | 76.40% | 105.47% | 95.57% | 70.83% | 100.42% |
| SG&A Expenses | 39.39% | 33.04% | 29.83% | 25.79% | 31.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.82% | 20.25% | 33.08% | 36.53% | 36.77% |
| Operating Income | 0.76% | 33.32% | 12.43% | -4.69% | 2.57% |
| Income Before Tax | 4.70% | 31.44% | 14.82% | -1.35% | 8.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 4.70% | 31.44% | 14.82% | -1.35% | 8.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.70% | 31.44% | 14.82% | -1.35% | 8.87% |
| EBIT | 0.76% | 33.32% | 12.43% | -4.69% | 2.57% |
| EBITDA | 1.90% | 35.35% | 14.07% | -2.31% | 4.06% |
| EPS Basic | 11.50% | 35.59% | 20.88% | 11.34% | 19.49% |
| Normalized Basic EPS | 11.48% | 35.58% | 20.88% | 11.32% | 19.49% |
| EPS Diluted | 11.50% | 35.59% | 20.88% | 11.34% | 19.49% |
| Normalized Diluted EPS | 11.48% | 35.58% | 20.88% | 11.32% | 19.49% |
| Average Basic Shares Outstanding | 7.66% | 6.42% | 7.66% | 14.31% | 13.19% |
| Average Diluted Shares Outstanding | 7.66% | 6.42% | 7.66% | 14.31% | 13.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |